Medicenna Therapeutics Common Stock

Medicenna Therapeutics (MDNA) currently reports a common stock of $100M as of September 2023. That compares with $100M in the prior-year period — down 0.1% year over year. Use the charts on this page to explore Medicenna Therapeutics's common stock history and peer comparisons.

Medicenna Therapeutics's common stock decreased from $100M to $100M — a 0.1% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Medicenna Therapeutics reported $100M in common stock as of September 2023. That compares with $100M in the prior-year period — down 0.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $100M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Medicenna Therapeutics, and consider following MDNA for alerts when major investors trade the stock.

Medicenna Therapeutics is classified in the Healthcare sector. On common stock, it currently shows $100M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MDNA with unrelated industries.